Choline

Choline

SCHEMBL147729

CCCC(=O)[O-].C[N+](C)(C)CCO

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Choline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ FFAR3 O14843 2/20 0.61
▸ HDAC3 O15379 2/20 0.61
▸ HDAC1 Q13547 2/20 0.61
▸ HDAC2 Q92769 2/20 0.61
▸ HDAC8 Q9BY41 2/20 0.61
▸ MEN1 O00255 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ SLC5A7 Q9GZV3 1/20 0.50
▸ BBOX1 O75936 9/20 0.45
▸ CA1 P00915 1/20 0.43
▸ CES2 O00748 1/20 0.40
▸ CES1 P23141 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL3191898 0.89 MEN1 (0.57) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL5574341 0.86 FFAR3 (0.67) FFAR3HDAC3HDAC1HDAC2HDAC8
Succinic Acid SCHEMBL27491383 0.86 MEN1 (0.62) FFAR3HDAC3HDAC1HDAC2HDAC8
Succinic Acid SCHEMBL6627654 0.86 CYP3A4 (0.62) FFAR3HDAC3HDAC1HDAC2HDAC8
Hexanoate SCHEMBL2762274 0.86 CA1 (0.54) BBOX1CA1CES2CES1
Glutarate SCHEMBL17982129 0.84 MEN1 (0.52) MEN1LMNAKMT2ACYP3A4SLC5A7
Stearic Acid SCHEMBL840883 0.84 FABP3 (0.55) BBOX1CA1CES2CES1
Octanoic Acid SCHEMBL2761867 0.84 FABP3 (0.55) BBOX1CA1CES2CES1
Myristic Acid SCHEMBL8588822 0.84 FABP3 (0.55) BBOX1CA1CES2CES1
Dodecanoate SCHEMBL19253062 0.84 FABP3 (0.55) BBOX1CA1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119913767-A Method for extracting cellulose from biomass raw material 中国石油化工股份有限公司 2025-05-02 — — CN claimed
CN-118058284-A Fatty acid choline salt soluble solution and preparation method and application thereof 郑州郑氏化工产品有限公司 2024-05-24 — — CN claimed
CN-116836098-B Method for extracting and purifying astaxanthin from fermentation broth 山东福瑞达生物科技有限公司 2024-05-07 — — CN claimed
CN-116836098-A Method for extracting and purifying astaxanthin from fermentation broth 山东福瑞达生物科技有限公司 2023-10-03 — — CN claimed
US-11642322-B2 Food supplement and composition comprising choline butyrate salt and/or butyrylcholine ABERGAVENNY NV (BE) 2023-05-09 — — US claimed
EP-3448170-B1 CHOLINE BUTYRATE SALT ABERGAVENNY NV (BE) 2022-03-16 — — EP claimed
US-11007159-B2 Food supplement and composition comprising choline butyrate salt and/or butyrylcholine ABERGAVENNY NV (BE) 2021-05-18 — — US claimed
US-20190117594-A1 FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE ABERGAVENNY NV (BE) 2019-04-25 — — US claimed
CN-105061799-B A kind of method that wheat stalk aeroge is prepared using choline butyrate 河南科技大学 2018-05-11 — — CN claimed
WO-2017187335-A1 FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE ABERGAVENNY NV (BE) 2017-11-02 — — WO claimed
CN-105061799-A Method for utilizing choline butyrate to prepare wheat straw aerogel UNIV HENAN SCIENCE & TECH 2015-11-18 — — CN claimed
EP-4748443-A2 SOLID COMPOSITION SUITABLE AS A NUTRITIONAL COMPOSITION OR SUPPLEMENT FOR ANIMALS THAT SUFFER FROM BRAIN RELATED DISORDERS, DECLINE OR DISEASES N.V. Nutricia (NL) 2026-05-27 — — EP disclosed
EP-4401580-B1 SOLID COMPOSITION SUITABLE AS A NUTRITIONAL COMPOSITION OR SUPPLEMENT FOR ANIMALS THAT SUFFER FROM BRAIN RELATED DISORDERS, DECLINE OR DISEASES NUTRICIA NV (NL) 2026-05-27 — — EP disclosed
CN-121574709-A Biomass-based dust suppressant and preparation method and application thereof 杭州格林微纳科技有限公司 2026-02-27 — — CN disclosed
EP-4493623-B1 PET DEPOLYMERIZATION PROCESS REPET S R L (IT) 2026-01-21 — — EP disclosed
CN-105061799-A Method for utilizing choline butyrate to prepare wheat straw aerogel UNIV HENAN SCIENCE & TECH 2015-11-18 — — CN disclosed
US-20120058057-A1 Anti-dandruff Agents MERCK PATENT GMBH (DE) 2012-03-08 — — US disclosed
WO-2011061687-A2 MULTIPLE-PHASE DIETARY SUPPLEMENT PRODUCT UNIVERSITY OF THE FREE STATE (ZA) 2011-05-26 — — WO disclosed
WO-2010136104-A2 ANTI-DANDRUFF AGENTS MERCK PATENT GMBH (DE) 2010-12-02 — — WO disclosed
US-5342530-A Using a cationic polyelectrolyte and salt mixture NALCO CHEMICAL COMPANY (US) 1994-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11642322-B2 Food supplement and composition comprising choline butyrate salt and/or butyrylcholine BCHE, CHAT, SLC10A2 FFAR3 129/4885HDAC3 142/4885HDAC1 704/4885
US-11007159-B2 Food supplement and composition comprising choline butyrate salt and/or butyrylcholine BCHE, CHAT, SLC10A2 FFAR3 129/4885HDAC3 142/4885HDAC1 704/4885
US-20190117594-A1 FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE BCHE, CHAT, SLC10A2 FFAR3 129/4885HDAC3 142/4885HDAC1 704/4885
US-20120058057-A1 Anti-dandruff Agents POLR1C, ETF1, PIK3C3 FFAR3 1689/4885HDAC3 171/4885HDAC1 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback